Four patients previously received anti-PD1/PD-L1 inhibitors; Cases 1, 2, 9 with gastric cancer and Case 6 with colorectal cancer had been previously treated with anti-PD1/PDL1 targeting treatment. Here, PDCD1 is linked to colorectal cancer.